ADAM metallopeptidase with thrombospondin type 1 motif 13
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The ADAMTS13 gene provides instructions for making an enzyme that is involved in regulating blood clotting. After an injury, clots normally protect the body by sealing off damaged blood vessels and preventing further blood loss.
Video picks for GenesVideo library
Normal function
The ADAMTS13 gene provides instructions for making an enzyme that is involved in regulating blood clotting. After an injury, clots normally protect the body by sealing off damaged blood vessels and preventing further blood loss.
The ADAMTS13 enzyme processes a large protein called von Willebrand factor. This protein is involved in the first step of blood clotting at the site of injury, which is to help cells called platelets stick together and attach to the walls of blood vessels, forming temporary clots. The ADAMTS13 enzyme cuts von Willebrand factor into smaller pieces to regulate its interaction with platelets. By processing von Willebrand factor in this way, the enzyme prevents it from triggering the formation of blood clots in normal circulation.
Conditions referring to this gene or chromosome
Other names
ADAM metallopeptidase with thrombospondin type 1 motif, 13
ADAMTS-13
ATS13_HUMAN
C9orf8
von Willebrand factor-cleaving protease
vWF-cleaving protease
vWF-CP
VWFCP
Patient picks for Genes

General health and lifestyle
Book a Pharmacy First online consultation
NHS Pharmacy First is a new scheme from the G... It allows patients to get treatment, including prescription medications where necessary, for common conditions without the need for a GP appointment. Through NHS Pharmacy First, My Local Surgery offers fast, free private online consultations with an NHS pharmacist for quick diagnosis and.
by Thomas Andrew Porteus, MBCS

Diabetes
MHRA approves teplizumab to delay progression of type 1 diabetes
Teplizumab (Tzield) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to help delay the onset of Stage 3 type 1 diabetes (T1D). Read on to see what this means if you are prescribed teplizumab and what it does for you.
by Lawrence Higgins

Diabetes
Adam Smith on mindfulness, mental health, and diabetes
Sky Sports presenter Adam Smith was diagnosed with type 1 diabetes just as his career was taking off. I caught up with Adam to discuss a day in his life and the challenges of managing the condition while working in the fast-paced world of live television. We also spoke about his support for the Mind in Range Collection, created in partnership with Omnipod and Calm. Adam shares how he uses mindfulness as a practical tool to help navigate the daily stresses of living with type 1 diabetes.
by Victoria Raw

Diabetes
Continuous glucose monitoring in type 1 diabetes
Type 1 and type 2 diabetes are both potentially serious conditions which should always be taken seriously. They’re both diagnosed on the basis of high blood sugar. But in other respects they are very, very different. Type 2 is largely down to lifestyle – getting type 1 is absolutely nothing to do with whether you eat too much sugar, carry excess weight or don’t exercise enough. People with type 2 diabetes often never need insulin – those with type 1 need it from day one. Many people with type 2 diabetes never need treatment that carries a risk of disabling low blood sugar (hypoglycaemia) – people with type 1 live with this risk every day. As a result, many people with type 2 never need to check their blood sugar several times a day – for people with type 1, it’s a highly unwelcome occupational hazard.
by Dr Sarah Jarvis

Podcasts
Losing it!
Why losing your erection doesn’t have to be the catastrophe you might think it is. Clare and Janet discuss ways to help with erection problems.
by Thomas Andrew Porteus, MBCS

Diabetes
Slowdown in type 2 diabetes cases
Some countries have seen a fall in new cases of type 2 diabetes according to a new review of the current evidence.
by Milly Evans
Related patient information and medicines

Patient information leaflet
Pregnancy screening tests
A small number of tests are abnormal. In these cases further assessment and/or treatment can be offered which may prevent serious problems. A midwife or doctor should discuss each test with you before it is done. Are pregnancy screening tests compulsory. No. If need be, an ultrasound scan Ultrasound scan can more accurately keep an eye on growth.

Patient information leaflet
Blood groups and types
ABO and rhesus are both types of antigens found on the surface of red blood cells. There are lots of other types but these are the most important. The main reasons to know your blood group are if you need to have a blood transfusion or if you are pregnant. What is a blood group. Red blood cells (erythrocytes) have certain proteins on their.

Patient information leaflet
Throat cancer
What is throat cancer. Throat cancer is a general term used to describe cancers of the throat. However, the throat includes other nearby structures as well as the voice box (larynx). Laryngeal cancer is just one type of cancer that can occur in the throat. Throat cancers and cancers that affect the mouth, are together all called oropharyngeal.

Patient information leaflet
Kidney cancer
Most cases of kidney cancer develop in people between the ages of 60 and 70 although it can affect any age group. The most common early symptom is blood in the urine. If kidney cancer is diagnosed at an early stage, there is a good chance of a cure. This is sometimes called renal adenocarcinoma or renal cell carcinoma or hypernephroma. Renal cell.

Patient information leaflet
Alpha-1 antitrypsin deficiency
In alpha-1 antitrypsin deficiency the result of a genetic abnormality leads to lung and, in some people, liver damage. Alpha-1 antitrypsin (A1AT) is a protein made by cells in the liver. It passes from the liver into the bloodstream and can travel to the lungs. If the balance tips and there is too much activity, lung tissue can start to become.

Patient information leaflet
BRCA genes
There are a few known gene changes (mutations) that can increase the risk of certain cancers, and tests available for some. The BRCA1 and BRCA2 genes normally protect against certain cancers, particularly breast cancer and ovarian cancer. If there is a mutation in one of these genes then this may mean that the protection is lost and that a cancer.
Further reading and references
- ADAM metallopeptidase with thrombospondin type 1 motif 13; MedlinePlus, National Library of Medicine.
- Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001 Oct 4;413(6855):488-94. doi: 10.1038/35097008.
- Tsai HM. Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost. 2003 Apr;1(4):625-31. doi: 10.1046/j.1538-7836.2003.00169.x. No abstract available.
- Tsai HM. Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update. Hematol Oncol Clin North Am. 2013 Jun;27(3):565-84. doi: 10.1016/j.hoc.2013.02.006.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

